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International Health Law
MICHELE FORZLEY, HEIDI P. FORSTER, SEEMA SHAH, AND EDMUND G. HOWE, III*
This article on recent events in international health law is divided into three parts:
(1) international research; (2) complementary and alternative medicine; and (3) other recent
developments.
I. International Research
In 2000, there were two major initiatives to revise the current thinking about interna-
tional human subjects research. First, the 52nd General Assembly of the World Medical
Association (WMA) voted to revise the Declaration of Helsinki for the fifth time since its
adoption in 1964.1 The Declaration of Helsinki consists of guidelines for biomedical re-
search involving human subjects. It has no legal force in the United States, but the guide-
lines do influence investigators, institutional review boards, and policy makers. Further-
more, in the new document the WMA asserts a change in the Declaration's status and
authority. The Declaration announces that it no longer serves as just "recommendations"
to physicians, and instead claims priority over national laws and regulations. The new Dec-
laration states "No national ethical, legal, or regulatory requirement should be allowed to
reduce or eliminate any of the protections for human subjects set forth in this Declaration."
The practical meaning of this asserted supremacy is unclear.
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1. WORLD MEDICAL ASSOCIATION, DECLARATION OF HELSINKI (2000), available at http://www.wma.net/e/
policy/17-c e.hunl (last visited Mar. 1, 2001).
2. Id. at provision 9.
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The Declaration was revised because of controversy over ambiguities in the language
used in its provisions. The WMA claims to have altered the document, in part, to make
clear that it is morally wrong to use placebos in studies in poorer countries if their use in
the same studies in wealthy countries would be considered unethical. Provision 29 states
that researchers must use the standard of "the best current prophylactic, diagnostic, and
therapeutic methods"3 for all subjects when conducting research. Under this change, pla-
cebo use is considered unethical when treatments are available for the disease or condition
under study.4 The use of placebos is only considered acceptable when no proven treatment
exists. If the new language were applied, many trials in the United States and abroad would
be considered "unethical." In response to the revisions, Greg Koski, director of the U.S.
Office for Human Research Protections stated, "I believe that it would be a mistake to rule
out the use of placebos in well-designed research .... I don't believe we would literally take
the declaration as the ... basis for new regulations."' Many researchers claim that the use
of placebos is scientifically necessary to effectively evaluate new drugs. Depending on the
study design and responsiveness to the host community, researchers also claim that the use
of placebos can be considered ethical. In addition, the Declaration addresses several im-
portant issues on which it was previously silent and revises its position on others. There
are new provisions guiding the obligations for monitoring and oversight of clinical research,
disclosure of financial conflicts of interest, and access to study drugs at the completion of
research.6
The second initiative to alter the conduct of international research came from the U.S.
National Bioethics Advisory Commission (NBAC). In 2000, NBAC released a draft of its
report tided Ethical and Policy Issues in International Research.7 The NBAC asserts that the
"purpose of th[e] report is to consider the ethical, legal, and policy issues that arise when
research that is subject to U.S. regulations, is sponsored or conducted in other countries."'
In the report, NBAC discusses issues such as recruitment of subjects, informed consent,
the risks and benefits of conducting multinational collaborative research, and obligations
of research sponsors to participants in research, host communities, and countries. NBAC
also investigates how and to what extent cultural and other factors influence these issues,
analyzes national and international guidelines and statements, and makes recommendations
about ways to enhance multinational collaborative research.
NBAC recommends: (1) limiting clinical trails in developing countries to those that are
responsive to the health needs of the host country; (2) designing trials that provide the
control group with an established, effective treatment; (3) involving community represen-
tatives in trial design and implementation of research; and (4) arranging to make successful
interventions available to participants at the conclusion of trials. In addition, NBAC in-
cludes recommendations about voluntary informed consent.
3. Id. at provision 29.
4. Liz McMillen, A World Medical Group Opposes Use of Placebos in Drug EAperiments, THE CHRONICLE OF
HIGHER EDuc., Oct. 9, 2000.
5. David Brown, Medical Research Group Revises Guidelines on Placebos, WASH. POST, Oct. 8, 2000, at A2.
6. For a more detailed analysis of the revisions, see Forster et al., The 2000 Revision of the Declaration of
Helsinki: A Step Forward or More Confision? (on file with author).
7. NATIONAL BIOETHICS ADVISORY COMMISSION, ETHICAL AND POLICY ISSUES IN INTERNATIONAL RESEARCH
(2000), available at http://bioethics.gov/toc.html. A copy may also be obtained by calling (301) 402-4242.
8. NATIONAL BIOETHICS ADVISORY COMMISSION, DRAFT REPORT: ETHICAL AND POLICY ISSUES IN INTERNA-
TIONAL RESEARCH PUBLIC COMMENT, available at http://bioethics.gov/report.html.
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II. Complementary and Alternative Medicine 9
A. UNITED STATES
By Executive Order 13,147 issued on March 7, 2000, President Clinton authorized the
establishment of the White House Commission on Complementary and Alternative Med-
icine Policy.10 The Commission is to report on legislative and administrative recommen-
dations for assuring that public policy maximizes the benefits of complementary and alter-
native medicine. In particular, the Commission is to address education and training,
research coordination, information delivery to the general public and the professions, and
access and delivery. Proceedings at the Commission can be followed through their website
at http://www.whccamp.hhs.gov.
B. FRANCE AND THE UNITED KINGDOM
A French national statute" permits the practice of specialites ancienne described as medic-
inal plants, whether indigenous or farmed, mixed or not. These may not be sold to the
public, except from pharmacies or herb stores (herbortisteries). In France there is also na-
tional regulation of the profession of the herboriste.12
The practice of acupuncture, in France and the United Kingdom, is not regulated."3 In
the United Kingdom, chiropractors and osteopaths have been regulated under a regime
very similar to the regulation of physicians. 14 In contrast, acupuncturists and homeopaths
must comply with local laws that render such practices unlawful if practiced without a
premises permit obtained from a local council. If an acupuncturist wanted to set up in
London for example, the London Local Authorities Act of 1991 requires a health practi-
tioner to establish that the particular practice specialty has an umbrella organization with
a code of conduct, insurance requirements, and disciplinary procedures in order to obtain
the permit. 5
Most countries regulate complementary and alternative medicine practices (CAM) to
some extent but space in this publication does not permit further discussion. In addition to
existing regulation, along the lines of the White House Commission, the UK Parliament's
Select Committee on Science and Technology issued its sixth report 16 on CAM on Novem-
9. For the purpose of Section II, complementary and alternative medicine and traditional medicine are
intended to mean the same activities.
10. Exec. Order No. 13,147, 65 Fed. Reg. 13,233 (Mar. 7, 2000).
11. Art. L. 659, C. Sant6 Publique (1998) (Fr.).
12. Id. at n.1.
13. Medicine Act, 1983 (Eng.).
14. Osteopath Act, 1993, c. 21 (Eng.). Earliest complementary modality to be licensed and most widelyused
in the United Kingdom. Elements copied into Chiropractor Act, 1994 (Eng.), include: registrar of chiroprac-
tors, educational committee, standards of proficiency, code of practice, disciplinary procedures, appeals process,
indemnity insurance requirements, and provisions that comply with EU rules, such as anti-competition, data
protection, and access to personal health information.
15. London Local Authorities Act, 1991, c. xiii (Eng.). It is unlawful to use a premises without a permit
from borough council. There are certain exceptions for medical practitioners or members of a body of health
practitioners where the body has codes of conduct, insurance requirements, and disciplinary procedures. This
rule applies to acupuncturists, massage therapists, and other healers.
16. Select Committee on Science and Technology Sixth Report on Complementary and Alternative Med-
icine (Nov. 21, 2000), available at http://www.parliament.the-stationery-office.co.uk/pa/d199900/dselect/
ldsctech/123/12302.htm.
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ber 28, 2000. The report calls for further regulation and research, noting among other
items, the need for standardized training and accreditation. The report further notes that
acupuncture, herbal medicine, and homeopathy have developed significant evidence to
moves towards statutory regulation.
C. THE EUROPEAN ECONOMIC COMMISSION
The European Economic Community (EEC) began to address the policy and regulatory
aspects of CAM much earlier than the United States and the United Kingdom. In 1995,
the European Council called for a study on generic medicinal products in the EEC Member
States and OECD countries including the United States, Canada, and Japan." In 1996, a
report emergeds covering diverse subjects such as the environment, marketing, animal
testing, genetic experimentation, biotechnology, mergers in the pharmaceutical industry
and more topics related to medicinals, including their impact on international trade. The
resolution embraces one of the directions established by the World Health Organization
(WHO) in its current strategic agenda, 9 which is to look at the links between health and
improved economic performance.
The report also urged the establishment of the Traditional Medicines Evaluation Agency
with an agenda to assess the worth of phytomedicines, to develop a responsible policy on
exports of medicinals, to draft a code of conduct for producers of medicinals for export to
the third world, to expend effort towards achieving harmonization of pharmaceutical reg-
istration under the framework of international conferences on harmonization (such as the
Hague Conference, UNIDROIT, and the UN), and that current intellectual property safe-
guards be maintained in line with TRIPS.20
On the issue of education and training, the EEC has established rules for the recognition
of diplomas and professional qualifications when the activity in question is not restricted to
a physician.2" Thus, a CAM practitioner can seek the acceptance of his or her credentials
in another state of the EEC based on a set of European-wide set of rules for recognition
of an educational background.
D. INTERNATIONAL TREATIES AND NON-GOVERNMENTAL ORGANIZATIONS
In the field of health, there are essentially no treaties directly on the subject of health
and there are certainly none on the subject of complementary and alternative medicine.
17. Council Resolution of 20 December 1995 on Medicinal Plant Preparations, 95/C 350/05.
18. Resolution on the communication to the Council and the European Parliament on the outlines of an
industrial policy for the pharmaceutical sector in the European Community 1996 OJ. (C 141) 63. The Office
of the Delegation of the European Economic Commission to the United Nations in New York assisted in
this query.
19. World Health Organization Strategic Agenda Statement at the 105th Session of the Executive Board
that launched the Commission on Macroeconomics and Health under Dr. Jeffrey Sachs, http://www.who.int/
wha-1998/eb1O5/PDF/ee2.pdf.
20. Trade Related Aspects of Intellectual Property Agreement (TRIPS), Dec. 15, 1993, 33 I.L.M. 81, is one
of the agreements of the General Agreement on Tariffs and Trade (GAIT), Dec. 15, 1993, 33 I.L.M. 28.
21. Written Question E-2932/98; Council Directive 89/48/EEC of21 December 1988 on a General System
for the Recognition of Higher-education Diplomas Awarded on Completion of Professional Education and
Training of at Least Three years' Duration, 1989 O.J. (L019) 16; Council Directive 92/51/EEC of 18 June
1992 on a Second General System for the Recognition of Professional Education and Training to Supplement
Directive 89/48/EEC, 1992 O.J. (L209) 25.
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Rather, health, and consequently CAM, is treated within a number of other treaties with
substantive import on such diverse topics as intellectual property law, the environment,
human rights, and biological diversity.
In 1993, the United States joined 158 other countries in signing the UN Convention on
Biological Diversity.22 The Convention seeks to achieve a fair and equitable sharing of the
benefits derived from the utilization of genetic resources that include plants and tropicals.
These are very much a component of the array of items considered traditional.
Most recently, the United Nations Committee on Economic, Social and Political Rights
reaffirmed 23 pursuant to Article 12(1) of the International Covenant on Economic, Social
and Cultural Rights (ICESCR),2 4 that every human being is entitled to the highest attainable
standard of health conducive to living a life in dignity, rather than simply living in the
absence of disease or infirmity. In this light, the Committee commented that availability,
accessibility, acceptability, and quality were the essential terms to achieve health. Regarding
accessibility, the Committee noted the following sub-elements: (1) non-discrimination,
physical accessibility or services within safe physical reach of all parts of the population;
(2) economic accessibility or affordability with payment to be based on the principle of
equity; and (3) information accessibility with its corresponding components of privacy and
confidentiality.
E. WORLD HEALTH ORGANIZATION
The World Health Organization (WHO), through the office of Traditional Medicine, is
undertaking a study of all member states to answer the questions that follow on the use of
traditional medicine. Traditional medicine is defined by the WHO as the ways of protecting
and restoring health that existed before modern medicine, using approaches that belong to
the cultural traditions of each country. The term can include acupuncture, traditional birth
attendants, mental healers, and herbal medicine. The questions included in the WHO
country study are: What is the extent of complementary medicine? What education and
training is available? What does the license to practice medicine include? Wdhat comple-
mentary medicines are covered under public and private insurance?
While the full report is not yet available, a sample report on Belgium25 demonstrates the
information the report will contain and how useful it will be. Assuming the data collected
for all countries is of similar quality, the report will be extremely useful to advance inter-
national and comparative research in this area.
mH. Other Recent Developments in International Health
A. REPRODUCTIVE ISSUES
The Japanese Health Ministry's Central Pharmaceutical Affairs Council has recom-
mended that the government permit women to use the birth control pill. Manufacturing,
22. Convention on Biological Diversity, Dec. 29, 1993, available at http://www.unep.ch/bio/conv-e.html.
23. 22nd session, April 25-May 12, 2000.
24. International Covenant on Economic, Social and Cultural Rights, G.A. Res. 2200A (XXI), U.N. GAOR Supp.
No. 16, U.N. Doc. A/6316 (1966). art. 12(1).
25. World Health Organization, Office of Traditional Medicine Draft Document, not available to the public
as of the date of this article. The author was given a copy of the section related to Belgium.
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Insurers in Britain can now use the results of genetic tests for Huntington's Disease to
refuse insurance coverage or increase premiums for beneficiaries who test positive. This
new legislation contravenes the advice of the Human Genetics Advisory Commission. Brit-
ain will be the first nation in which insurers can request genetic tests of people with family
histories of genetic disorders and demand to see the results of tests people have taken.27
Conversely, a recent court case in Hong Kong led to increased protection against genetic
discrimination. Three men were discriminated against for having a parent with schizo-
phrenia, which their employers argued put them at increased risk of developing the disease.
The judge ruled against the employers and found no threat to safety in the workplace.
Incidentally, the men have only a 4 percent chance of developing schizophrenia."
C. INFORMED CONSENT
A British court found undergoing surgical sterilization to be in the best interests of a
thirty-one-year-old woman with severe learning disabilities, though she was unable to con-
sent to the procedure. Evidence of sexual activity, concern about the risk of pregnancy, and
the potential harm of taking a child away from the woman motivated the decision.2 9
A lower court ruling (affirmed by Britain's Court of Appeals) resulted in the surgical
separation of conjoined twin girls against their parents' wishes. Physicians contended that
both girls would have died without the surgery, but with the surgery the stronger twin
would have an increased chance of survival. The weaker twin passed away after the operation
and though the stronger twin faces many more surgeries, she is expected to lead a relatively
normal life. 30
Over fifty South African physicians have been accused of testing people for HIV without
their consent at the request of their employer. The University of Witwatersrand AIDS Law
Project has brought suit on behalf of the people tested against the Health Practitioners
Association of South Africa. No one who was tested was offered counseling regarding the
results and the people who tested positive may be in danger of losing their jobs.3 1
D. INTELLECTUAL PROPERTY RIGHTS
A bureaucratic error led to the University of Edinburgh being granted a patent that covers
techniques of preparing transgenic humans. The European Patent Office issued a patent
26. Associated Press,Japan: Pill Makers Approved, N.Y. TIMES, June 17, 1999.
27. See Roger Highfield, Insurers get approval to use genetic tests, DAILY TELEGRAPH (U.K.), Oct. 13, 2000,
available at http://www.telegraph.co.uk.
28. See Robin McKie, China is Thwarted by Jobs Ruling, GUARnIAN (UK), Oct. 1, 2000, available at http://
www.guardian.co.uk/Archive/Article/0,4273,4070400,00.html.
29. In Re X, 2 F.L.R. 1124 (Farn. 1998), available at 1998 WL 1042916.
30. See Russell Jenkins, Siamese Twin Jodie is Bright and Flourishing, TIMES (London) Dec. 16, 2000, at
http://www.thetimes.co.uk/article/0,,2-52463,00.htnl; T.R. Reid, Life.br One Twin, or Death for Both? WASH.
PosT, Sept. 7, 2000, at Al.
31. See Secret HIV Tests Alleged in S. Africa, A.P., Aug. 26, 2000.
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for, among other things, a procedure to create a "transgenic animal" from purified stem
cells. As critics have noted, humans are animals, so this patent violates European guidelines
that prohibit the patenting of methods of genetic manipulation in humans. In February
2000, a rally was held in Munich to protest the granting of this patent. Though the error
has been officially admitted, there are administrative barriers that will prolong the resolu-
tion of the mishap.32
E. GLOBAL INEQUITIES
Two recent studies have shown that the cost of prescription drugs in Africa is much higher
than in the developed world. A drug that prevents transmission of HIV from a pregnant
woman to her fetus, Nevirapine, costs $874 in Kenya, almost twice what it costs in Norway.
Measuring the relative cost of medicine in terms of hourly wages, a resident of Tanzania
would have to work 500 hours to afford a tuberculosis treatment while someone in Swit-
zerland would have to work for an hour to purchase the same treatment."
F. END OF LIFE
After British clinicians decided to withdraw care from David Glass, a severely disabled
twelve-year-old, his mother brought suit to ensure he would continue to be treated. The
High Court of Britain cited the difficulty of decision-making in life and death situations
and deferred to the judgment of the clinicians to let David die peacefully.14
The Dutch lower house of Parliament passed a bill that legalizes physician-assisted sui-
cide. Though the bill has yet to be reviewed by the upper chamber, approval is viewed as
a mere formality. Euthanasia is a crime in the Netherlands, but in 1993, Parliament ap-
proved guidelines for the practice of euthanasia that physicians could follow without fear
of prosecution (such as first determining that the patient's suffering is "unbearable"). The
new bill would reverse the presumption that currently exists-physicians who euthanize
patients will no longer be committing a crime for which they may be exempt from prose-
cution. Instead, euthanasia that is consistent with the guidelines will be a legal act. When
there is doubt that the guidelines have been followed, a physician's actions would be ex-
amined by a regional review committee composed of doctors."
G. SEXUALITY
Among the most important of international legal issues is, of course, human rights. These
rights include protecting persons not only from discrimination because of race, religion,
and gender, but discrimination based on sexual preference, as well. Furthering rights in this
area will be an important task in the United States and throughout the world in the decades
to come. The court case described here concerns persons whose rights have just, however,
begun to be addressed: persons who are transsexual. In this country, there have been just a
few such cases, and only a handful of foreign countries have even considered this issue.
32. See Michael Hagmann, Protest Leads Europeans to Confess Patent Error, 287 Sci. 1567 (2000).
33. Donald G. McNeil, Jr., Prices for Medicine Are Exorbitant in Africa, Study Says, N.Y. TIMES, June 17,
2000.
34. See Ian Murray, A Gray LegalArea, TIMES (London), Apr. 22-23, 1999.
35. See Keith B. Richburg, Netherlands Moves to Legalize Assisted Suicide, WASH. POST, Nov. 29, 2000, at A32.
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A few introductory comments about persons who are transsexual are in order. Transsexual
persons are those who for some reason or experience themselves as being in "the wrong
body" or as being of the "wrong" sex. Their emotional pain often exists from early infancy
and is, all too frequently, excruciating. They usually keep these painful feelings "in the
closet" during their youth and, unless they are fortunate enough to be able to obtain medical
help, as some can in this country, they may stay in this closet throughout their lifetime.
Those who can pursue a change in their body to "become a person of the opposite sex" do
this through surgery and taking hormones. They also receive counseling.
Yet, there are often large gaps in their acquiring these medical interventions. Their lives
during these gaps, again, can be excruciating. They may, for example, receive hormone
treatments initially but, then, have to wait several more years to acquire the funds to un-
dergo surgery. And in some cases, the success of these interventions remains inherently,
irreversibly limited. Men who have reached maturity may, for example, already have ex-
perienced a deepening in their voice brought about by male hormones that have changed
their larynx. As a result, their voices may never become softer or higher, even as a result of
surgical intervention and hormones. Consequently, though they can appear female in other
respects, they may not to the extent that they retain a deeper voice.
In light of a transexual's needs and situation, an appellate case of first impression recently
decided in the United States is highly significant. In Littonton v. Prange,36 a transsexual
woman who had been born a man sued a doctor as a "surviving spouse." This court's
summary statement of the question before it was on point: "The deeper philosophic (and
now legal) question is: can a physical change the gender of a person with a scalpel, drugs
and counseling, or is a person's gender immutably fixed by our Creator at birth."
37
The Plaintiff had been born with normal male genitalia but from the age of three or four
years old she felt, inside, "like a girl." After years of difficulties such as feeling embarrassed
changing in front of boys, she underwent hormonal treatments, sexual reassignment sur-
gery, and psychiatric counseling. Her doctors testified that psychologically she was a female
"before and after" surgery and that she "functioned" sexually after surgery "as a female.""
She married a man in 1989 who died in 1996. She subsequently filed a medical mal-
practice suit as her husband's surviving spouse under the Texas Wrongful Death and Sur-
vival Statute. The doctor defended by challenging her claim as a wrongful death beneficiary,
asserting she was a man.
The trial court agreed with the doctor on the basis that despite her and her husband
having had a ceremonial marriage, Texas statutory law did not permit marriage between
persons of the same sex. The Texas Court of Appeals, believed, however, that statutory law
did not resolve this question. Rather the question they believed critical was "Is Christie a
man or a woman?"39
The court recited the relevant history of law regarding transsexual persons. In the first
such case, an English court decided that, legally, gender was determined at birth. 4° The
36. Littleton v. Prange, 9 S.W.3d 223 (Tex. App. 1999).
37. Id. at 223.
38. Id. at 224.
39. Id.
40. Corbett v. Corbett, 2 All E.R. 33 (1970), available in 1970 WL 29661.
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court also cited an unreported New Zealand case in which, unlike the case in England, the
court ruled "for the transsexual" because "the alternative would be more disturbing."'41
The court also discussed the only U.S. case that had gone the other way.42 The trial
court's opinion in this case is remarkable: "Miff the psychological choice . . .is .. .not a
mere whim, and irreversible sex reassignment surgery has been performed, society has no
right to prohibit the transsexual for leading a normal life. Are we to look upon this person
as an exhibit in a circus sideshow? '43 The appellate court affirmed this lower court's ruling,
stating that it perceived "no legal barrier, cognizable social taboo, or reason grounded in
public policy" to rule otherwise."
The appellate court in the Littleton case concluded that although Christie had made
"every conceivable effort to make herself a female,... [tihere are some things we cannot
will into being. They just are. '45 Thus, Christie was deemed a male, as a matter of law.
41. Id. at 229 (citing Mary Coombs, Sexual Dis-Orientation: Transgendered People and Same-sex marriage,
8 U.C.L.A. WOMEN'S LJ. 219, 250 n.137 (1998).
42. See M.T. v. J.T., 140 N.J. Super. 77, 355 A.2d 204 (1976).
43. Id. at 207.
44. Id. at 210-11.
45. Littleton, 9 S.W.3d at 230-31.
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